CRL logo

CRL Charles River Laboratories International, Inc.

New York Stock Exchange · Medical - Diagnostics & Research · Healthcare

$335.13
-2.84 (-0.84%)

Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, a…

Market Cap: $16.06Bwww.criver.com

Price

$314.32+5.60%
$272.88$307.29$341.69$376.10
Aug 25Nov 20

Social Signal Score

51
5d
50
6 mentions
-5.4%
30d
50
60 mentions
-9.0%
60d
51
116 mentions
+13.3%
90d
52
168 mentions
+5.3%
rss: 127 · 4chan: 16 · news: 23 · podcast: 1 · finnhub: 1

Analyst Ratings

37 analysts
Buyconsensus
Strong Buy 1Buy 27Hold 9Sell 0Strong Sell 0
Avg price target$313.67-5.6%
Low $219Median $330High $388
Current Consensus

52-week range

$149.93$376.10
Last close
$314.32
Off 52w high
-16.4%
200-day average
$230.87
vs 200-day
+36.1%

Compare with other stocks off their highs

Revenue

$982.73M+110.53%
$445.76M$663.79M$881.82M$1.10B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$10.24
$10.18–$10.28
13 analysts
FY2026
$11.47+12% YoY
$11.23–$11.59
9 analysts
FY2027
$12.93+13% YoY
$12.65–$13.58
9 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Birgit Girshick
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
19,000
Beta
1.34
Country
US
Piotroski score
8 / 9 (Strong)
Altman Z-score
3.26
www.criver.com